减脂

Tirzepatide

5mg*10vials USD 40.00
10mg*10vials USD 60.00
15mg*10vials USD 70.00
20mg*10vials USD 88.00
30mg*10vials USD 116.00
40mg*10vials USD 140.00
50mg*10vials USD 180.00
60mg*10vials USD 210.00
100mg*10vials USD 350.00

参考价。付款前由客服确认金额。

产品代码 TR

库存 0

4.5 / 5 · 3022 条评论

订单提交后，与客服联系时请报出订单号。

产品特色

Dual-target fat reduction, blood sugar control, and weight loss

产品简介

Tirzepatide is a dual incretin receptor agonist composed of 39 amino acids. It activates both GLP-1 and GIP receptors, thereby enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite. With a half-life of approximately 5 days, it is convenient to administer via a once-weekly subcutaneous injection. Clinical trials have demonstrated that tirzepatide offers superior efficacy in terms of glycemic control and weight loss compared to selective GLP-1 receptor agonists.

注意事项

Reconstitution: Add 2.0 mL of sterile water → concentration becomes 2.5 mg/mL Typical weekly dosage range: 2.5–15 mg once weekly (titrated gradually, every 4 weeks) Easy measurement: At 2.5 mg/mL, 1 unit = 0.01 mL = 25 micrograms

使用方式

1. Use a sterile syringe to draw 2.0 mL of bacteriostatic water. 2. Inject slowly along the inner wall of the vial; avoid creating bubbles. 3. Gently rotate/roll the vial until the contents are dissolved (do not shake). 4. Label with the date of reconstitution; store refrigerated at 2–8°C and protect from light. 5. Use within 28 days of reconstitution.

储存方式

Lyophilized: Store in the original sealed vial at -20°C; keep dry and protected from light. After reconstitution: Store refrigerated at 2–8°C; use within 4 weeks for optimal stability. Avoid freeze-thaw cycles: Do not refreeze the reconstit

4.5 / 5

3022 条评论

显示最近 100 条。

★★★★★

VXD•••••••7109

澳大利亚

2026-10-25 03:55

Support confirmed the destination before dispatch. The batch note was readable. The support note helped.
★★★★★

VXB•••••••8B87

加拿大

2026-10-25 00:02

The parcel stayed sealed in transit. Nothing was missing. Simple and correct.
★★★★★

VX7•••••••5CD8

其他

2026-10-24 20:09

Checkout and the shipping note were both clear. The closure was clean. Happy with the packing.
★★★★★

VX1•••••••A5BD

加拿大

2026-10-24 16:17

Support confirmed the destination before dispatch. The contents were undamaged. Pleased with how it was sent.
★★★★★

VX7•••••••E035

澳大利亚

2026-10-24 12:24

Shipping was straightforward. The label was easy to read. It arrived exactly as described.
★★★★★

VX1•••••••FC67

英国

2026-10-24 08:31

The carton was dry and closed. The order form and the parcel agreed. Clear from start to finish.
★★★★★

VXD•••••••2F3D

英国

2026-10-24 04:38

The listing photo matched the parcel. The contents were undamaged. Clear from start to finish.
★★★★★

VXC•••••••FD47

美国

2026-10-24 00:46

The route was slower than the estimate. The contents were complete. Packing did its job.
★★★★★

VX3•••••••9562

法国

2026-10-23 20:53

Everything listed was in the box. The seal was clean and unbroken. Happy with the packing.
★★★★★

VX6•••••••BD3B

美国

2026-10-23 17:00

Delivery was on time. The packing list was right. Everything checked out.

买家评论

填写下单时的订单号和电话号码。两者必须与包含这个商品的订单一致。

其他在架商品

减脂

Cagrilintide

Cagrilintide is a long-acting, acylated amylin analogue—a pancreatic hormone—designed for once-weekly subcutaneous injection. It activates central amylin receptors, promoting satiety, slowing gastric emptying, and reducing food intake. In Phase 2 and Phase 3 clinical trials, cagrilintide induced dose-dependent weight loss, with side effects primarily being gastrointestinal in nature.

4.6

参考价USD 113.00

减脂

CJC-1295+IPA(CP10)

This formulation combines CJC-1295 (without DAC)—a modified growth hormone-releasing hormone (GHRH) analog—with Ipamorelin, a selective growth hormone secretagogue (GHS). CJC-1295 (without DAC) produces a sustained, dose-dependent increase in GH and IGF-1 levels, while Ipamorelin selectively stimulates GH release without increasing ACTH or cortisol.

4.9

参考价USD 116.00

减脂

Retatrutide

Retatrutide is an investigational triple-receptor agonist peptide (targeting GLP-1, GIP, and glucagon receptors) currently under development for the treatment of obesity and type 2 diabetes. Phase II clinical trials have demonstrated significant weight loss, with patients in the high-dose group achieving a weight reduction of up to 24% over 48 weeks. This educational program outlines a once-weekly subcutaneous administration regimen, incorporating a gradual dose-escalation approach to minimize gastrointestinal side effects.

4.2

参考价USD 45.00

减脂

Tesamorelin

Tesamorelin is a synthetic 44-amino acid peptide analog that resembles growth hormone-releasing hormone (GHRH). It stimulates the release of endogenous growth hormone and increases IGF-1 levels, thereby promoting lipolysis and providing metabolic benefits. Tesamorelin has been approved by the FDA for the reduction of visceral adipose tissue in individuals with HIV-associated lipodystrophy.

5.0

参考价USD 41.00